High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia - A single center study

被引:24
作者
Mitterbauer, M
Laczika, K
Novak, M
Mitterbauer, G
Hilgarth, B
Pirc-Danoewinata, H
Schwarzinger, I
Haas, OA
Fonatsch, C
Lechner, K
Jaeger, U
机构
[1] Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria
[2] Univ Vienna, Childrens Canc Res Inst, St Anna Childrens Hosp, Vienna, Austria
[3] Univ Vienna, Ludwig Boltzmann Inst Cytogenet Diag, Vienna, Austria
[4] Univ Vienna, Dept Lab Med, Vienna, Austria
[5] Univ Vienna, Dept Med Biol, Vienna, Austria
关键词
acute myeloid leukemia; inv(16); CBF beta/MYH11; reverse transcriptase-polymerase chain reaction; RT-PCR;
D O I
10.1309/D94U-351N-HT3D-F1F3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Identification of the inversion 16 in patients with acute myeloid leukemia (AML) is of great practical value since these patients have a relatively favorable prognosis, especially wizen treated with high-nose cytarabine. We compared the results of cytogenetic analysis and reverse transcriptase-polymerase chain reaction (RT-PCR)for core binding factor (CBF) beta/myosin heavy chain (MYH11) in 241 unselected cases of AML. In contrast with other studies, we found a high concordance between these 2 methods. Eighteen of 241 patients showed a cytogenetic anomaly of the chromosome 16 We detected the fusion transcript by RT-PCR ii? ail 18 eases and in 2 additional patients with AML without any cytogenetic anomaly of chromosome 16 One patient had a normal diploid karyotype, and the second patient showed a trisomy, 22 in karyotype analysis, which often is associated with im,(16). Only 8 of 20 CBF betn/MYH11-positive patients had M4Eo morphologic features. The much higher discrepancy between cytogenetic analysis and RT-PCR in other studies, especially, in AMLs other than M4Eo, possibly indicates the necessity for PCR screening regardless of the French-American-British classification.
引用
收藏
页码:406 / 410
页数:5
相关论文
共 38 条
[1]   INVERSION OF CHROMOSOME-16 AND BONE-MARROW EOSINOPHILIA IN A MYELOMONOCYTIC TRANSFORMATION OF CHRONIC MYELOID-LEUKEMIA [J].
ASOU, N ;
SANADA, I ;
TANAKA, K ;
HIDAKA, M ;
SUZUSHIMA, H ;
MATSUZAKI, H ;
KAWANO, F ;
TAKATSUKI, K .
CANCER GENETICS AND CYTOGENETICS, 1992, 61 (02) :197-200
[2]   PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :620-625
[3]   CYTOGENETIC STUDIES ON 519 CONSECUTIVE DENOVO ACUTE NONLYMPHOCYTIC LEUKEMIAS [J].
BERGER, R ;
FLANDRIN, G ;
BERNHEIM, A ;
LECONIAT, M ;
VECCHIONE, D ;
PACOT, A ;
DERRE, J ;
DANIEL, MT ;
VALENSI, F ;
SIGAUX, F ;
OCHOANOGUERA, ME .
CANCER GENETICS AND CYTOGENETICS, 1987, 29 (01) :9-21
[4]   ASSOCIATIONS BETWEEN MORPHOLOGY, KARYOTYPE, AND CLINICAL-FEATURES IN MYELOID LEUKEMIAS [J].
BITTER, MA ;
LEBEAU, MM ;
ROWLEY, JD ;
LARSON, RA ;
GOLOMB, HM ;
VARDIMAN, JW .
HUMAN PATHOLOGY, 1987, 18 (03) :211-225
[5]  
Bloomfield CD, 1998, CANCER RES, V58, P4173
[6]  
BLOOMFIELD CD, 1994, BLOOD, V84, pA111
[7]   DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE [J].
CAMPANA, D ;
PUI, CH .
BLOOD, 1995, 85 (06) :1416-1434
[8]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[9]  
CLAXTON DF, 1994, BLOOD, V83, P1750
[10]  
ENRIGHT H, 1992, LEUKEMIA, V6, P381